[go: up one dir, main page]

AU2000261861A1 - Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom - Google Patents

Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom

Info

Publication number
AU2000261861A1
AU2000261861A1 AU2000261861A AU6186100A AU2000261861A1 AU 2000261861 A1 AU2000261861 A1 AU 2000261861A1 AU 2000261861 A AU2000261861 A AU 2000261861A AU 6186100 A AU6186100 A AU 6186100A AU 2000261861 A1 AU2000261861 A1 AU 2000261861A1
Authority
AU
Australia
Prior art keywords
hepatitis
fusion protein
gene expression
mass production
expression system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000261861A
Inventor
Seong Il Choi
Soo-Il Chung
Seung-Won Jin
Ha-Jung Kim
Mi-Kyung Min
Baik-Lin Seong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Mogam Biotechnology Research Institute
PROTHEON Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Mogam Biotechnology Research Institute
PROTHEON Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Mogam Biotechnology Research Institute, PROTHEON Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of AU2000261861A1 publication Critical patent/AU2000261861A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2000261861A 2000-07-28 2000-07-28 Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom Abandoned AU2000261861A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2000/000825 WO2002010396A1 (en) 2000-07-28 2000-07-28 Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom

Publications (1)

Publication Number Publication Date
AU2000261861A1 true AU2000261861A1 (en) 2002-02-13

Family

ID=19198245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000261861A Abandoned AU2000261861A1 (en) 2000-07-28 2000-07-28 Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom

Country Status (2)

Country Link
AU (1) AU2000261861A1 (en)
WO (1) WO2002010396A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI651094B (en) * 2013-10-21 2019-02-21 日商大鵬藥品工業股份有限公司 Novel CTL epitope 4 linked peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100203919B1 (en) * 1996-10-04 1999-06-15 신동권 New Expression Plasmids Producing Water-Soluble Proteins

Also Published As

Publication number Publication date
WO2002010396A1 (en) 2002-02-07
WO2002010396A9 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
AU5579699A (en) Rapid amperometric verification of pcr amplification of dna
WO2000077233A3 (en) Complement-resistant non-mammalian dna viruses and uses thereof
AU2003284689A1 (en) NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO
AU2002365912A1 (en) Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
EP1256628A3 (en) Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
WO2002006457A3 (en) Novel lipase genes
EP1436397A4 (en) VACCINE AGAINST HEPATITIS C VIRUS
HK1044962A1 (en) Process for nucleic acid purification using silicon carbide
AU6974496A (en) Methods of using nucleotide integrase for cleaving dna and attaching nucleic acids
AU2001273559A1 (en) Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids
AU6203700A (en) Hybridization of target dna with immobilized nucleic acid analogs
WO2002022826A3 (en) Methods and compositions for the construction and use of fusion libraries
AU2000261861A1 (en) Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom
AU5452300A (en) Target amplification of nucleic acid with mutant rna polymerase
WO2001064912A3 (en) Triazine degrading enzymes
AU2003220136A1 (en) RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
AU2001249245A1 (en) Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme
AU2438501A (en) Expression of proteins from amplified, immobilized nucleic acids
AU1855001A (en) A new member of the pak protein family, nucleic acids and methods related to thesame
WO1990012488A3 (en) A clone of double-stranded rna virus applied to antibody production, study of retrovirus-like frameshifting and production of proteins in yeast
AU7893501A (en) Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins
AU2405300A (en) Uses of flavivirus rna-dependent rna polymerases
AU8258198A (en) Separation of nucleic acids by antibodies to halogenated nucleotides
AU6235000A (en) Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
AU783309C (en) Oligonucleotide primers for efficient reverse transcription of hepatitis C virus (HCV) RNA and methods of use thereof